Jennifer Jarrett Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jennifer Jarrett.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jennifer Jarrett. Jennifer Jarrett is a Chief Financial Officer in MEDIVATION, INC. ($MDVN) and a Director in ARENA PHARMACEUTICALS INC ($ARNA) and a in Syndax Pharmaceuticals Inc ($SNDX) and a Director in Audentes Therapeutics, Inc. ($BOLD) and a Chief Operating Officer in Arcus Biosciences, Inc. ($RCUS) and a Director in Arcus Biosciences, Inc. ($RCUS) and a See Remarks in Arcus Biosciences, Inc. ($RCUS).
Address: C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO 94105 CA
Companies in which Jennifer Jarrett is an Insider
Arcus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer Jarrett: Chief Operating Officer, Director, See Remarks
Holdings: 116,973 shares
Latest Transaction: Mar 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARENA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer Jarrett: Director
Holdings: 11,217 shares
Current Value: $16,713
Latest Transaction: Jun 15 2021
$ARNA Market Capitalization: $357.67M
$ARNA Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jennifer Jarrett: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 15 2020
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDIVATION, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer Jarrett: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Sep 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syndax Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer Jarrett:
Holdings: 16,000 shares
Current Value: $139,040
Latest Transaction: Feb 05 2021
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jennifer Jarrett
Sentiment: All, RCUS, ARNA, BOLD, MDVN, SNDX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
| Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 3,067 | 0 | 11,217 | 8.2 K to 11.2 K (+37.63 %) |
| Mar 18 2021 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Chief Operating Off ... | Sell | S | 35.03 | 8,661 | 303,394 | 116,973 | 125.6 K to 117 K (-6.89 %) |
| Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Jarrett Jennifer | Grant | A | 0.00 | 16,000 | 0 | 16,000 | 0 to 16 K | |
| Jan 20 2021 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Chief Operating Off ... | Grant | A | 0.00 | 400,000 | 0 | 500,634 | 100.6 K to 500.6 K (+397.48 %) |
| Oct 05 2020 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Chief Operating Off ... | Option Exercise | A | 17.17 | 900,000 | 15,453,000 | 900,000 | |
| Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 |